CD274 and cancer: In this regard, the gut microbiota has been involved in the efficacy of anti-PD1 and anti-PDL1 immunotherapies (Frankel et al., 2017; Matson et al., 2018; Peters et al., 2019), further confirming the crucial role of microbiota in cancer.